The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Estimated costs of managing treatment-related adverse events (TRAEs) of nivolumab (nivo) and docetaxel (doc) in the CheckMate 017 and CheckMate 057 phase III non-small cell lung cancer (NSCLC) trials.
 
Meena Venkatachalam
Employment - Parexel
Consulting or Advisory Role - Parexel
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
David D. Stenehjem
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Guilhem Pietri
Employment - Parexel
 
John R. Penrod
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Beata Korytowsky
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb